Earnings History Data for G1 Therapeutics, Inc. (GTHX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

G1 Therapeutics, Inc.

G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engaged in developing novel, small-molecule therapies which address significant unmet needs in the treatment of cancer. The company's product pipeline consists of CDK4/6, Trilaciclib (G1T28), G1T38 and G1T48. G1 Therapeutics, Inc. is based in Research Triangle Park, NC.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
03-08-2022 PM 6:30 AM ET
(Aug 3)
GTHX G1 Therapeutics, Inc. 349.76 -0.92 -1.04 -0.94 G1 Therapeutics GAAP EPS of -$0.92 beats by $0.10, revenue of $10.57M beats by $1.7M
[8/3/2022 6:34 AM]
8.70 0.40 
(4.82%)
8.61 0.31 
(3.73%)
3.84 - 17.23 2,406,015 730,000 6,733
04-05-2022 PM 6:30 AM ET
(May 4)
GTHX G1 Therapeutics 220.00 -1.15 -0.99 0.00 G1 Therapeutics GAAP EPS of -$1.15 misses by $0.17, revenue of $6.9M beats by $0.78M
[5/4/2022 6:32 AM]
5.46 0.0 
(0.00%)
5.46 -0.01 
(-0.18%)
4.91 - 24.12 785,465 650,000 16,139
23-02-2022 PM 6:30 AM ET
(Feb 23)
GTHX G1 Therapeutics, Inc. 407.36 -0.94 -1.03 -0.67 G1 Therapeutics GAAP EPS of -$0.94 beats by $0.09, revenue of $5.79M beats by $0.07M
[2/23/2022 6:34 AM]
9.78 0.14 
(1.45%)
9.95 0.31 
(3.22%)
8.04 - 26.69 670,795 670,000 10,605
03-11-2021 PM 0:00 AM ET
(Nov 3)
GTHX G1 Therapeutics, Inc. 642.42 -1.00 -1.03 -0.31 G1 Therapeutics EPS beats by $2.02, beats on revenue
[11/3/2021 6:39 AM]
16.16 0.97 
(6.39%)
14.50 -0.69 
(-4.54%)
11.32 - 37.07 1,496,864 880,000 54,424
04-08-2021 AH 4:00 PM ET
(Aug 4)
GTHX G1 Therapeutics, Inc. 724.10 -0.94 -0.96 -0.83 G1 Therapeutics EPS beats by $0.04, beats on revenue
[8/4/2021 4:09 PM]
16.14 -0.58 
(-3.47%)
16.10 -0.62 
(-3.71%)
10.81 - 37.07 1,059,379 720,000 36,965
05-05-2021 AH 4:00 PM ET
(May 5)
GTHX G1 Therapeutics, Inc. 884.08 -0.65 -1.09 -0.82 G1 Therapeutics EPS beats by $0.42, beats on revenue
[5/5/2021 4:05 PM]
19.57 -0.20 
(-1.01%)
19.57 0.0 
(0.00%)
10.81 - 37.07 2,010,974 860,000 23,800
24-02-2021 AH 4:00 PM ET
(Feb 24)
GTHX G1 Therapeutics, Inc. 981.97 -0.67 -0.88 -0.94 G1 Therapeutics EPS beats by $0.23, beats on revenue
[2/24/2021 4:28 PM]
22.45 -2.69 
(-10.70%)
25.69 0.55 
(2.19%)
8.80 - 37.07 2,723,822 2,671,563 23,256
04-11-2020 AH 4:00 PM ET
(Nov 4)
GTHX G1 Therapeutics, Inc. 426.14 -0.31 -0.25 -0.86 G1 Therapeutics EPS misses by $0.01, beats on revenue, FY20 guidance update
[11/4/2020 4:16 PM]
12.08 0.18 
(1.51%)
12.60 0.70 
(5.88%)
8.80 - 31.38 1,021,751 940,679 4,286
05-08-2020 AH 4:00 PM ET
(Aug 5)
GTHX G1 Therapeutics, Inc. 553.61 -0.83 -0.82 -0.82 G1 Therapeutics EPS in-line, misses on revenue
[8/5/2020 4:16 PM]
17.00 1.44 
(9.22%)
16.70 1.13 
(7.26%)
8.80 - 41.80 534,029 534,739 9,107
06-05-2020 AH GTHX G1 Therapeutics, Inc. 508.32 -0.82 -0.98 -0.64 0.0 0.0 
(0.00%)
0.0 0.0 
(0.00%)
0.0 - 0.0 0 0 0